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ABSTRACT When nicotinic acetylcholine receptors are reconstituted into lipid bilayers lacking cholesterol, agonists no
longer stimulate cation flux. The kinetics of this process are difficult to study because variations in vesicle morphology cause
errors in flux measurements. We developed a new stopped-flow fluorescence assay to study activation independently of
vesicle morphology. When receptors were rapidly mixed with agonist plus ethidium, the earliest fluorescence increase
reported the fraction of channels that opened and their apparent rate of fast desensitization. These processes were absent
when the receptor was reconstituted into dioleoylphosphatidylcholine or into a mixture of that lipid with dioleoylphosphatidic
acid (12 mol%), even though a fluorescent agonist reported that resting-state receptors were still present. The agonist-
induced channel opening probability increased with bilayer cholesterol, with a midpoint value of 9 ± 1.7 mol% and a Hill
coefficient of 1.9 ± 0.69, reaching a plateau above 20-30 mol% cholesterol that was equal to the native value. On the other
hand, the observed fast desensitization rate was comparable to that for native membranes from the lowest cholesterol
concentration examined (5 mol%). Thus the ability to reach the open state after activation varies with the cholesterol
concentration in the bilayer, whereas the rate of the open state to fast desensitized state transition is unaffected. The
structural basis for this is unknown, but an interesting corollary is that the channels of newly synthesized receptors are not
fully primed by cholesterol until they are inserted into the plasma membrane-a novel form of posttranslational processing.
INTRODUCTION
The role of cholesterol in modulating the properties of
phospholipid bilayers has been extensively studied, but its
role in lipid-protein interactions is less well understood
(reviewed in Barrantes, 1993). For example, in the recon-
stituted (Ca2+-Mg2+)-ATPase from sarcoplasmic reticu-
lum, a cholesterol analog could either inhibit or activate the
enzyme, depending on the composition of the surrounding
phospholipids (Lee et al., 1994). Similarly, in a ligand-gated
ion channel, the nicotinic acetylcholine receptor (nAcChoR)
from Torpedo, cholesterol, or the hemisuccinate is required
for activation of the channel (Fong and McNamee, 1986). In
neither protein is cholesterol's action associated with its
effect on bulk lipid bilayer fluidity (Lee et al., 1994; Sun-
shine and McNamee, 1994), although an action on the lipid
adjacent to the protein, suggested for the (Ca2+-Mg2+)-
ATPase from sarcoplasmic reticulum (Squier and Thomas,
1988), remains a possibility (Sunshine and McNamee,
1994). In both proteins evidence has been presented for the
existence of nonannular, or interstitial, sites within the pro-
tein that are distinct from the lipid-protein interface (Jones
and McNamee, 1988; Narayanaswami and McNamee,
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1993; Lee et al., 1994). However, there is no evidence
directly supporting a functional role for the putative nonan-
nular cholesterol sites. Indeed, activity is maintained in the
nAcChoR when a variety of hydrophobic compounds are
substituted for cholesterol. This observation challenges the
nonannular site hypothesis, which is now required to pos-
tulate very lax structure-activity requirements (Sunshine
and McNamee, 1992).
The aim of this study was to investigate quantitatively the
role of cholesterol in the agonist-induced rapid state transi-
tions associated with channel opening in the AcChoR.
Rapid cation flux measurements are the obvious way to
extend the previous phenomenological observations (Walker
et al., 1982; Fernandez et al., 1993; Fernandez-Ballester et al.,
1994), but they suffer from severe experimental drawbacks
because the measured flux rate depends on the morphology of
the vesicles, which may vary with lipid composition (Anholt et
al., 1982). Specifically, controls would need to be perforned to
correct for variation in vesicle internal volume and receptor
surface density, as well as for inhomogeneities in the vesicle
population, and there is no rapid and secure way of doing so
(Udgaonkar and Hess, 1986). Furthermore, sealed vesicles are
not formed when the receptor is reconstituted into some lipid
bilayers (Pradier and McNamee, 1992). Therefore, we devel-
oped an assay using the fluorescent probe ethidium bromide,
whose interaction with the AcChoR has been characterized
(Schimerlik et al., 1979; Herz et al., 1987, 1991; Pedersen,
1995). We find that after rapid mixing of receptors with agonist
and ethidium, the earliest fluorescence increase reports the
fraction of channels that opened and the rate of fast desensiti-
zation. Exploiting this new assay, we show that the ability to
reach the open state after agonist binding depends on the
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cholesterol concentration in the bilayer, whereas the rate of fast
desensitization is unaffected.
MATERIALS AND METHODS
Materials
Torpedo nobiliana were obtained live from Biofish Associates (George-
town, MA). All phospholipids were purchased from Avanti Polar lipids
(Alabaster, AL), cholesterol was from Calbiochem (La Jolla, CA). Affigel
102, acrylamide, bis-acrylamide, and Coomassie brilliant blue were from
Biorad (Richmond, CA). Spectra/Por tubing for dialysis was from Spec-
trum Medical Industries (Houston, TX). 86Rb+ and [3H]acetic anhydride
were obtained from New England Nuclear (Billerica, MA). Dithiothreitol
(DTT) and bromoacetyl bromide were purchased from Fisher Biotech
(Pittsburgh, PA). Choline bromide, EDTA, EGTA, phenylmethylsulfonyl
fluoride, and dns-choline (1-(5-dimethylaminonaphthalene-1-sulfonamido)
ethane-2-trimethylammonium) were purchased from Sigma (St. Louis,
MO), and all other chemicals were obtained from Aldrich (Milwaukee,
WI), unless otherwise stated.
Bromoacetylcholine bromide was synthesized from choline bromide
and bromoacetyl bromide (Damle et al., 1978). [3H]Acetylcholine iodide
was synthesized from [3H]acetic anhydride and ,B-dimethylaminoethanol
(Anjaneyulu, 1985). Dns-C6-Cho ([1-(5-dimethylamino naphthalene)sul-
fonamido]n-hexanoic acid b-(N-trimethylammonium bromide) ethyl ester)
was synthesized by a published method (Waksman et al., 1976).
Preparation of nAcChoR-rich membranes from
Torpedo nobiliana
Receptor-rich membranes were obtained from the electric organ of Tor-
pedo nobiliana and prepared for reconstitution in homogenization buffer
(10 mM NaH2PO4, 5 mM EDTA, 5 mM EGTA, 0.02% NaN3 at pH 7.4)
made 0.1 mM in phenylmethylsulfonyl fluoride and 10 mM in iodoacet-
amide immediately before use (McCarthy and Moore, 1992). Native nAc-
ChoR membranes were prepared as previously described (Braswell et al.,
1984). Membrane suspensions were kept frozen at -80°C until used.
Purification and reconstitution of nAcChoR by
affinity chromatography
nAcChoR was purified and reconstituted into lipid vesicles by a modifi-
cation of a published procedure (Ellena et al., 1983) in which Affi-gel 102
was used in place of Affi-gel 401. It was derivatized with DL-N-acetyl
homocysteine thiolactone and then modified with bromoacetylcholine bro-
mide. Rereconstitution by lipid substitution was performed according a
published method (Ochoa et al., 1983). The ratio of phospholipid to
receptor was generally in the range of 250-500:1 (mol:mol), but a few
preparations were prepared at higher and lower lipid ratios (4000-140:1).
Depletion of cholesterol from reconstituted nAcChoR samples by using
cholesterol-free liposomes was performed as described previously (Leibel
et al., 1987).
Characterization of reconstituted nAcChoR
Protein concentration (Markwell et al., 1978), phospholipid content (Mc-
Clare, 1971), and cholesterol content (Rudel and Morris, 1973) were
determined by standard methods. All bilayer compositions are given in
mol%. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (Laem-
mli, 1970) was performed under denaturing conditions to verify the identity
and purity of the receptor. Two methods were used to determine the
concentration of agonist-binding sites. First, by competition with the flu-
orescent cholinergic ligand, (dansylaminoethyl) trimethylammonium per-
chlorate (Dns-Cho), by acetylcholine (Neubig and Cohen, 1979) and,
second, by a [3H]AcCho-binding assay (Braswell et al., 1984). Receptor
concentration refers to the oligomer unless agonist sites are specified (two
agonist sites per oligomer).
Electron microscopy
Reconstituted nAcChoR samples were visualized by electron microscopy.
Small squares of carbon-coated mica were cut out, and a drop of dilute
nAcChoR in buffer A was placed on the edge of each square, with capillary
action forcing the sample down between the carbon and the mica. The mica
square was floated on stain solution, 1% sodium silicotungstate in water
(the carbon with the sample floated on the surface while the mica sank to
the bottom), and a copper grid was placed over the carbon on the stain
surface and the sample allowed to stain for 1 min. The copper grid with
the sample adhering to it was removed and air dried.
Steady-state fluorescence experiments
with ethidium
Steady-state fluorescence experiments were carried out according to a
published method (Herz et al., 1987). In brief, ethidium (1 JIM) was
dissolved in Torpedo physiological saline (250 mM NaCl, 5 mM KCl, 3
mM CaCl2, 2mM MgCl2, 5 mM sodium phosphate, and 0.02% NaN3 at pH
7.0), and an emission spectrum was acquired with an SLM DMX-1000
spectrofluorimeter. Ethidium fluorescence was stimulated by using an
excitation wavelength of Aex = 500 nm; each emission spectrum was
scanned from 525 to 700 nm. Experiments were performed at 20°C. An
aliquot of native membranes (final concentration 2 ,uM acetylcholine sites)
was then added to the quartz cuvette and an emission spectrum acquired.
Carbachol (carbamylcholine; final concentration 1 mM) was then added,
and the corresponding emission spectrum recorded. A final spectrum was
acquired in the presence of 500 AM phencyclidine (PCP) to determine the
extent of nondisplaceable ethidium binding. Samples were corrected for
dilution effects.
Stopped-flow fluorescence energy transfer experiments were performed
with a BioSX-17 MV spectrofluorimeter, with a 150-W xenon lamp
equipped with a input monochromator and with a filter at the collection
port; a T-mixer is integrated into the quartz optical cell (Applied Photo-
physics, Leatherhead, England). All experiments were carried out at 20 ±
0.4°C in Torpedo physiological saline. Equal volumes of fluorophore (plus
ligands where appropriate) solution and nAcChoR vesicle suspension were
rapidly mixed to give a final receptor concentration of 0.2 ,uM, equivalent
to 0.4 ,uM in acetylcholine-binding sites. Tryptophan residues were excited
at 290 nm (0.5-mm slit), and the binding of ethidium or Dns-C6-Cho was
recorded with a 530-nm high-bandpass cutoff filter. Between four and eight
traces were acquired digitally for each set of conditions and then signal
averaged. Each trace (2000 data points) was acquired for 500 s in the
logarithmic timebase mode. Data collection was continued if the reaction
did not reach equilibrium within this time.
When required, brief preincubations of receptor with one of the ligands
was carried out with the BioSX-17 MV configured in the sequential mixer
mode.
Traces of fluorescence intensity versus time were fit to an equation of
the sum of the appropriate number of exponentials as described previously
(Raines et al., 1995). If the rates and amplitudes of each exponent were
determined as a function of agonist concentration, they were fit by a
nonlinear least-squares routine to the logistic equation
([A]n +xrp0) (1)
where x, xmax, and x,,l,, are the rates (x = k) or amplitudes (x = F) observed
at the experimental, [A], highest, and lowest agonist concentrations, re-
spectively; n is the Hill coefficient; and EC50 is the half-effect concentra-
tion. Errors given are standard deviations unless otherwise noted.
Rankin et al. 2447
Volume 73 November 1997
Channel inhibition
The net efflux of 86Rb+ from sealed native vesicles elicited during 10-s
exposure to carbachol (10 mM) at 4°C was measured in the presence of the
increasing concentrations of ethidium to determine its inhibition curve as
previously described (Forman et al., 1987).
RESULTS
Establishing the kinetic paradigm
Titration of carbachol-induced state transitions
When nAcChoRs (0.2 ,uM) were rapidly mixed with
ethidium (0.2 ,uM) and increasing concentrations of carba-
chol (2.5 nM to 25 mM), a series of traces were obtained
(Fig. 1). Low concentrations of carbachol ('2.5 ,uM) re-
sulted in fluorescence traces resembling those obtained for
ethidium alone, in which the major fraction of the intensity
only began to develop after 10 s. However, at higher con-
centrations (>10 ,uM carbachol), fluorescence increased
strongly, with a major increase occurring between 100 ms
and a few seconds, after which a plateau was achieved and
maintained until - 100 s had elapsed. Beyond this, a further
slow increase occurred, paralleling, with a slight lag, that
seen at lower carbachol concentrations. The traces at low
carbachol concentrations were best fit to the sum of two
exponentials (called "fast" (time constant of 2 s) and "slow"
(time constant of 140 s)), but above -10 ,uM carbachol a
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FIGURE 1 Effect of carbachol on fluorescence traces of ethidium-la-
beled native nAcChoR membranes. Native membranes were rapidly mixed
to give 0.2 ,uM receptors with 0.2 ,uM ethidium plus the following
carbachol concentrations in the stopped-flow fluorimeter's cell: (i) no
carbachol, (ii) 2.5 ,uM, (iii) 25 ,uM, (iv) 250 ,uM, and (v) 25 mM. All traces
were corrected for nondisplaceable binding and have been normalized to
the maximum fluorescence obtained with 2.5 ,uM carbachol at 2000 s. The
line through the 25 mM data is the nonlinear least-squares fit. The inset
shows the same traces represented on a linear time scale.
third exponent (designated "early") was necessary. The
slow component of ethidium fluorescence represents slow
desensitization and has been characterized previously
(Quast et al., 1979; Herz et al., 1987). In the present work,
we wish to focus on the rapid, agonist-induced component,
particularly the early one.
The early component
The fractional amplitude of the early component was insig-
nificant below 2.5 ,AM carbachol, but increased rapidly
above 10 ,xM, to reach a plateau of 20-30% of the total
amplitude (Fig. 2). The apparent rate of this component also
increased with carbachol concentrations above 10 ,uM to
reach a plateau above 1 mM (Fig. 3). The carbachol con-
centration for the half-maximum rate was 0.22 ± 0.046
mM, and the Hill coefficient was 0.9 ± 0.16.
When the carbachol concentration was held constant at
25 mM and the ethidium concentration varied, the observed
rate was independent of ethidium concentration in both
native and reconstituted membranes. Because the nonspe-
cific binding was so low, the relationship was best examined
in reconstituted receptors. In two preparations with the
composition PC:phosphatidic acid:Chol (30 mol%), the ob-
served rate was independent of the ethidium concentration
from 0.2 to 25 ,uM; a linear fit had a slope of -1.6 (± 1.1)
104 M-1 s-' (p = 0.2) and an intercept of 2.9 ± 0.32 s-1.
Similar results were obtained for native membranes over the
1.0..1.
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FIGURE 2 The fractional amplitudes of the three components of
ethidium fluorescence as a function of carbachol concentration. The traces,
such as those in Fig. 1 from native membranes, were fit to an equation that
was the sum of three exponentials after nondisplaceable binding had been
subtracted. *, Early component; V, fast component; O, slow component.
The curves for the slow and early components were determined by non-
linear least-squares fitting; the curve for the fast component represents the
remaining relative amplitude.
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FIGURE 3 Carbachol concentration dependence of the apparent rate of
the early component. The traces, such as those in Fig. 1, were fit to an
equation that was the sum of three exponentials after nondisplaceable
binding had been subtracted. Results for native membranes (OL) are from
two separate titrations not presented in Fig. 2, and those for reconstituted
membranes (0; DOPC:DOPA:Chol (36%)) are from a single experiment.
The data have been normalized to the maximum rate to aid comparison.
Parameters of the native membrane curve (Eq. 1): maximum rate 7.3 ±
0.36 s- , carbachol concentration at half-maximum rate (EC50) 220 ± 46
,uM, and Hill coefficient 0.9 ± 0.16. Comparable parameters for the
reconstituted membrane: 2.75 ± 0.14, 120 ± 45 ,LM, and 0.8 ± 0.21.
range 0.1-5 ,uM ethidium (p = 0.6). The absolute amplitude
increased sigmoidally, but the relative amplitude remained
constant.
The fast component
Unlike the early component, the fast component was even
observed in the absence of carbachol. It contributed 12 ±
1.8% of the total fluorescence up to 1 ,AM carbachol, above
which the relative amplitude increased sharply, with a mid-
point of 5 ,AM and a maximum of 45 ± 2.6% of the total
amplitude at 100 ,AM carbachol. The increasing fractional
amplitude of the fast component mirrors the decreasing
amplitude of the slow component as the carbachol concen-
tration increases. Their midpoints and the absolute values of
their Hill coefficients were identical within error. Above
100 ,AM carbachol, the absolute amplitude of the fast com-
ponent was constant, whereas the relative amplitude fell
because the amplitude of the early component increased
over the same concentration range (Fig. 2). The apparent
rate of this component also increased sigmoidally from
0.19 ± 0.029 s-1 up to 1 ,AM carbachol to 0.66 ± 0.037 s-
above 100 ,uM carbachol, with a half-maximum rate at 26 ±
5.4 ,AM and a Hill coefficient between 1 and 2.
When ethidium was titrated in native and reconstituted
membranes in the presence of high concentrations of car-
bachol as described in the above section, the fast compo-
nent's apparent rate was also independent of ethidium con-
centration. Its absolute amplitude increased sigmoidally
with increasing ethidium concentration, but its relative am-
plitude (35 ± 5.6%, Fig. 2) was independent of ethidium
concentration. However, in the absence of carbachol, its
relative amplitude was only 17 ± 3.6% and the observed
rate independent of ethidium concentration.
Effect of preconditioning the nAcChoR with carbachol
With the stopped-flow fluorimeter in sequential mixing
mode, nAcChoRs and carbachol were rapidly mixed and
forced into an aging tube, where their concentrations were
0.4 ,uM and 30 mM, respectively. After 10 s the contents of
the aging tube were rapidly mixed with carbachol and
ethidium at the second mixer, to give final concentrations in
the optical cell of 0.2 ,uM nAcChoR, 1.0 ,uM ethidium, and
30 mM carbachol. Fig. 4 compares 1) the simultaneous
mixing of receptors with carbachol and ethidium and 2)
receptors preconditioned with carbachol and then mixed
with ethidium. The early component, which had a total
amplitude in the control experiment of 117 ± 1.4 mV, was
completely abolished by preincubation with carbachol for
10 s.
Similar results were obtained using nAcChoRs reconsti-
tuted into 1,2-dioleoyl-sn-glycero-3-phosphocholine/1,2-
dioleoyl-sn-glycero-3-phosphate/cholesterol (DOPC/DO-
PA/cholesterol) vesicles with a molar ratio of 63/12/25
under the same conditions as above.
Ethidium inhibits agonist-induced cation flux
Ethidium's apparent affinity for the open state was esti-
mated from its ability to inhibit maximum-carbachol stim-
a.)
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a.)
0u:
0
U
0.0 PE
0.0 0.5 1.0
Time (s)
1.5 2.0
FIGURE 4 The effect on ethidium fluorescence of preconditioning the
nAcChoR with carbachol. Trace i is native membranes rapidly mixed with
ethidium and carbachol to give 0.4 ,uM sites, 1 ,uM ethidium, and 30 mM
carbachol. Trace ii is native receptor incubated with carbachol for 10 s and
then rapidly mixed with ethidium (final concentrations were 0.4 ,uM ACh
sites, 30 mM carbachol, and 1 ,uM ethidium). Traces have been corrected
for nondisplaceable binding.
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ulated 86Rb+ efflux. Using a 10-s manual assay (Forman et
al., 1987), it was found that above 10 ,uM, ethidium caused
a concentration-dependent inhibition, which was essentially
complete at 300 ,uM and had an IC50 of 40 ± 12 ptM and
a Hill coefficient of 1.4 ± 0.39.
Nondisplaceable binding of ethidium
Nonspecific binding of ethidium was resolved either by
preincubating nAcChoRs with 500 ,uM PCP, with or with-
out 10 mM carbachol, and rapidly mixing them with
ethidium, or by adding all of the ligands simultaneously to
the nAcChoRs. The two methods gave identical results.
Fluorescence followed a single exponential. Nondisplace-
able binding in native membranes was -6% and 20% of the
total amplitude at 0.2 and 2 ,kM ethidium, respectively. In
reconstituted samples, nondisplaceable binding was -9%
of the total amplitude at 2 ,uM ethidium, considerably lower
than in native membranes, and the rate of the early compo-
nent was independent of ethidium concentration, justifying
the strategy of using 2 ,uM ethidium to enhance the signal of
scarce reconstituted preparations.
The effects of lipid bilayer composition
Characteristics of reconstituted membranes
Affinity-purified and reconstituted membranes contained
only the four AcChoR subunits plus minor high-molecular-
weight components at .100 kDa. Electron micrographs of
these membranes revealed only the well-known rosette-
shaped receptor independent of the lipid composition. Na-
tive membranes formed large vesicles that were inhomoge-
neous in size, whereas those formed with receptors in
DOPC:EPA:Chol (60:12:28) were smaller. Receptors re-
constituted in DOPC:EPA (88:12) exhibited a mixture of
both sausage-shaped vesicles and sheets, whereas in DOPC
only sheets were seen. This lipid-dependent morphology is
consistent with reports in the literature (Pradier and Mc-
Namee, 1992).
Role of lipid in carbachol-induced state transitions
In an initial survey, receptors (0.2 ,tM) were rapidly mixed
with ethidium (2 ,uM) plus carbachol (0, 3 ,iM or 10 mM;
all final concentrations). At the lower concentration most of
the fluorescence derived from the slow component, whereas
at the higher concentration the early and fast components
were dominant. The four representative reconstituted recep-
tors surveyed had lipid compositions of DOPC, DOPC:Chol
(28%), DOPC:DOPA, and DOPC:DOPA:Chol (25%),
where the molar proportion of DOPA was kept constant at
12% of the total lipid because this reproduces the average
charge density in native membranes, assuming that the
average negative charge is 1.5 per molecule of DOPA (Pott
At 0 and 3 ,uM carbachol, the composition of the bilayer
had very little effect on the kinetics (not shown). In contrast,
10 mM carbachol (Fig. 5) revealed dramatic differences
between the four reconstituted membranes at subsecond
times: only those containing cholesterol supported fast ag-
onist-induced transitions independent of the presence of
DOPA. Over the full 2000 s of the experiment, the traces for
the cholesterol-containing bilayers had to be fit to four
exponentials, whereas the others could be fit to three. The
rates and amplitudes of all components were all comparable
to those for native membranes.
Cholesterol titration
Receptors were reconstituted into bilayers of DOPC:DOPA:
Chol in the proportions ({ 88 - x}: 12:x), where x was varied
from 0 to 50 mol% and confirmed experimentally. Typical
traces from single experiments with 10 mM carbachol il-
lustrate the effect of increasing the mol% of cholesterol in
the bilayer from 0 to 24% (Fig. 6). In the region where the
early component was fully established (-0.5-1 s), the am-
plitude of the traces increased with cholesterol content most
markedly at the lowest cholesterol contents examined.
To verify that there was no residual activity in reconsti-
tuted receptors lacking cholesterol, we examined six differ-
ent preparations containing no cholesterol, three each of
DOPC and DOPC:DOPA. Nonspecific binding was sub-
tracted in all cases; it was small and usually less than 5% of
total amplitude. To confirm these subtractions, we sub-
tracted the uncorrected traces with and without carbachol.
Both subtraction methods failed to reveal any early compo-
nent in the absence of cholesterol.
0.4
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FIGURE 5 The effect of lipid composition on the state transitions in-
duced by a saturating concentration of agonist (10 mM carbachol) detected
with 2 ,M ethidium. Final AcChoR concentration was 0.2 ,uM. Traces are
averages of 4-6 shots and have been normalized to the maximum fluo-
rescence obtained at 2,000 s. Trace i is DOPC:DOPA:Chol (63:12;25);
trace ii is DOPC:Chol (72:28); trace iii (dotted trace) is DOPC:DOPA
et al., 1995).
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give final concentrations of 0.2 and 2 ,uM, respectively,
yielding traces that could be fit to four exponentials. The
two fastest exponentials represent Dns-C6-Cho binding to
the preexisting slow and fast desensitized conformations of
the receptor (Raines et al., 1995). The amplitudes of these
two exponentials varied little with lipid composition and
were close to those previously reported for native mem-
branes; that of the first exponent was 15-24% and that of
the second exponent was 12-30%. The remaining amplitude
reflects receptors that slowly convert from the resting to the
high-affinity desensitized states. Thus the percentage of
receptors initially in the low-affinity resting state was cal-
culated to be 47 ± 2.9, 54 ± 6.5, and 61 ± 2.1 for DOPC,
DOPC:DOPA, and DOPC:DOPA:Chol, respectively, com-
pared to 57% in native membranes under the same conditions.
Time(s)
FIGURE 6 Effect of cholesterol on state transitions induced by a satu-
rating concentration of agonist (10 mM carbachol). AcChoRs were recon-
stituted into a bilayer of DOPC:DOPA:Chol in the proportions ((88 -
x):12:x), where x has the value shown. Final AcChoR and ethidium
concentrations were 0.2 ,uM and 2 ,uM, respectively; traces have been
normalized to the maximum fluorescence obtained at 2000 s with 2.5 ,uM
carbachol.
To provide controls for the process of reconstitution, a
number of samples were obtained by postpurification ma-
nipulations. For example, a preparation with 42% choles-
terol was depleted of cholesterol by incubation with DOPC
vesicles to give samples of 30 and 5 mol% cholesterol.
Similarly, the two highest cholesterol concentrations were
achieved by lipid substitution (rereconstitution) from a
DOPC sample. None of these samples differed notably from
similar samples prepared on the column.
Another variable surveyed briefly was the role of poly-
unsaturation. In one sample with 28% cholesterol, egg phos-
phatidylcholine was substituted for DOPC (there was no
phosphatidic acid (PA)), and in another with 43% choles-
terol EPA was substituted for DOPA. Neither of these
variations had any effect.
Carbachol titration
The carbachol dependence of the apparent early rate in a
DOPC:DOPA:Chol (36%) membrane was very similar to
that of native membranes (Fig. 3) that have a half-maximum
rate at 120 ± 45 ,uM carbachol and a Hill coefficient of
0.8 ± 0.21. The fast component rate also showed a carba-
chol dependence very similar to that of native membranes
that have a half-maximum rate at 32 ± 20 ,uM carbachol
and a Hill coefficient of 1.1 ± 0.1.
Studies with a fluorescent agonist
Receptors reconstituted in DOPC, DOPC:DOPA, or DOPC:
DOPA:Chol (21%) were rapidly mixed with Dns-C6-Cho to
DISCUSSION
Rapid ethidium kinetics
The early component
The early component's rate was independent of ethidium
concentration and therefore indicates a conformational
change. The maximum observed rate is very close to that for
fast desensitization, which we have determined in rapid flux
studies in Torpedo nobiliana membranes (Forman and
Miller, 1988). Similar rates have been reported for Electro-
phorus (Hess et al., 1982) and for Torpedo californica
(Walker et al., 1982). Such a carbachol-induced increase in
quantum yield would be analogous to that detected without
change in [3H]ethidium binding on the desensitized state
(Schimerlik et al., 1979). The carbachol dependence of fast
desensitization (via flux studies) in T. californica mem-
branes reconstituted into asolectin or in Electrophorus has a
half-point of -1 mM carbachol for fast desensitization
(Walker et al., 1982; Hess et al., 1982), somewhat higher
than the value we observe. The origin of the small differ-
ence might be either the different species and conditions or
that flux reports a global change in all of the subunits,
whereas ethidium reports more selectively.
At what point before the quantum yield increase accom-
panying the A2RP` --> A2F step does ethidium bind? Based
on our data, it seems likely that ethidium is a slow open
channel blocker. We have found that the early component's
amplitude is decreased by procaine and by self-inhibitory
concentrations of carbachol (>100 mM), which suggests a
location on the open state of the receptor (Forman and
Miller, 1989) such that its quantum yield increases upon
desensitization as the aqueous pore closes (Scheme I). This
likely explains the high apparent IC50 reported by our flux
assay, because during the assay the majority of the 86Rb+ is
released in the first 30 ms. Procaine's on rate at this site is
2.5 X 105 M-1 s-' (Forman and Miller, 1989), and a much
larger molecule like ethidium would be expected to be
considerably slower. The resting state can be excluded both
because it is estimated by radiolabel and fluorescence bind-
ing assays to have an affinity for ethidium of only 0.1-1
_
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mM (Schimerlik et al., 1979; Cohen et al., 1985; Herz et al.,
1987) and because brief preincubation with ethidium did not
enhance the early component. Furthermore, we can expect
that carbachol binding and channel opening will occur in the
deadtime of our instrument (<1 Ims). We did observe en-
hanced ethidium fluorescence in the deadtime, which in-
creased with ethidium concentration, but this binding was
nonspecific and not displaced by PCP. The only ligand
affecting deadtime fluorescence was carbachol, which
caused a small decrease consistent with ethidium's reported
low-affinity binding to the agonist site (Pedersen, 1995).
Thus it is clear that the early component allows us to
achieve our first goal of monitoring the occurrence of the
transient states induced by high carbachol concentrations
without the necessity of conducting flux experiments. The
fact that we are monitoring transient conformational states
is clear when we force all of the receptor into the fast
desensitized state by a 10-s preincubation of carbachol with
the receptor (Fig. 4). The addition of ethidium at this point
reveals the total loss of the early component, indicating that
the transient state to which it binds is no longer available.
bilayer clearly revealed, especially in the fast state transi-
tions. There was no evidence for substantial changes in the
distribution of states existing in the absence of agonist due
to the differing lipid compositions examined. The most
dramatic effect was the absolute dependence of the early
component's amplitude on cholesterol content but not on
other variables, such as polyunsaturation, lipid:protein ratio,
surface charge, or the membrane changes associated with
the reconstitution procedure (Figs. 5-7). This effect was
clearly present at the lowest cholesterol concentration we
examined (5 mol%). In contrast, the rate of the early com-
ponent, representing fast desensitization, was insensitive to
any manipulation (Fig. 7).
Our evidence suggests that carbachol binds the resting
state receptors but fails to open the channel unless choles-
terol is present. Referring to Scheme I and recalling that the
proportion of R state receptors is not strongly affected by
lipid composition, the absence of cholesterol could either
prevent the transition from the activated to the fast desen-
sitized state or the attainment of the activated state. The
E
R \ \ A2R \ \ A2Ropen \ ' A2RopenE
A2FE*
Scheme 1
The fast component
This component was observed in the absence of carbachol,
where it represents 15% of the total fluorescence ampli-
tude; with carbachol the maximum amplitude was -36%.
In each case the observed rate is independent of ethidium
concentration. The dependence of the observed rate on
carbachol concentration had a half-maximum of -30 ,uM
carbachol. Similarly, the slow component of ethidium flu-
orescence was also independent of ethidium concentration
but was dependent on carbachol, with a half-maximum rate
at 4 ,uM carbachol (Rankin, 1996). It is possible that these
processes represent conformational changes associated with
preexisting fast and slow desensitized receptors, but more
detailed assignments were not attempted because this com-
ponent was found not to vary with lipid composition.
The role of lipids in rapid state transitions
In the absence of agonist, all of the lipid mixtures exhibited
interactions with ethidium, but only when activating con-
centrations of agonist were added was the role of the lipid
former explanation is unlikely because the rate and ampli-
tude of the early component depend on cholesterol in dif-
ferent ways and because prior experiments indicate that no
agonist-dependent transmembrane cation flux is observed in
the absence of cholesterol (Fong and McNamee, 1986). The
early component might, therefore, be absent because carba-
chol fails to activate resting-state receptors through lack of
either efficacy or affinity. The latter possibility is difficult to
rule out completely, because at the high concentrations
required to test this hypothesis, carbachol binds to the
channel inhibition site on the receptor with an apparent
dissociation constant of -200 mM (Forman et al., 1987).
However, in cholesterol-free membranes we found that con-
centrations of carbachol as high as 200 mM failed to pro-
mote the early component. Therefore it follows that choles-
terol is intimately involved in receptor activation, and lack
of it lowers carbachol's efficacy to zero.
Slow flux studies (Fong and McNamee, 1986; Sunshine
and McNamee, 1992; Perez-Ramirez, 1994) and prelimi-
nary rapid flux studies (Fernandez et al., 1993; Fernandez-
Ballester et al., 1994) have also demonstrated the need for
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FIGURE 7 The amplitude, but not the rate, of the early component
depends on the mol% of cholesterol in the bilayer. Traces, such as those in
Fig. 6, were fit to the sum of three or four exponentials after nondisplace-
able binding had been subtracted. The curves shown in the lower panel
were determined by nonlinear least-squares fitting. In the upper panel the
solid line is the mean and the dashed lines the standard deviations of the
reconstituted membranes (4.7 ± 1.2; n = 19); the comparable values in
native membranes were not significantly different. *, DOPC:DOPA:Chol
in the proportions ({88 -x}:12:x); 7, DOPC:Chol in the proportions
({ 100 -x} :x); C], native membranes. Symbols without error bars (standard
deviations) represent a single experiment. The six zero cholesterol points
are means of three preparations each for DOPC:DOPA and DOPC. The
curve has a maximum fractional amplitude of 0.46 ± 0.052, a cholesterol
concentration at half maximum amplitude (EC50) of 9 ± 1.7 mol%, and a
Hill coefficient of 1.9 + 0.69.
cholesterol for agonist-induced channel activation. How-
ever, because flux assays are sensitive to the morphology of
the vesicles, these workers were unable to make detailed
comparisons between different lipids. The advantage of
using ethidium is particularly clear when AcChoRs are
reconstituted into DOPC, which forms sheets incapable of
trapping ions. It is now possible to conclude unequivocally
that channel activation does not occur in DOPC membranes.
Our work differs in one other respect from previous
studies: we find that the presence of DOPA in DOPC
confers no particular advantage, whereas others have found
that the slight flux response of DOPC:Chol reconstitutions
was dramatically enhanced by the addition of DOPA (Fong
and McNamee, 1986). The explanation for this may lie in
vesicle morphology, because negatively charged lipids
tended to increase the internal volume of vesicles.
Mechanistic basis for cholesterol's action
A priori, a number of mechanisms might explain the role of
cholesterol in agonist-induced activation. These include 1)
lipid fluidity; 2) aggregation; 3) binding of cholesterol to
specific sites on the receptor but not in the lipid-protein
interface (nonannular or interstitial sites); 4) an action in the
lipid-protein interface, such as hydrophobic mismatching
between the dimensions of the bilayer and the hydrophobic
region of the receptor (Bloom et al., 1991); and 5) a change
in intrinsic curvature brought about by conformationally
induced perturbation. Our data only allow us to comment on
some of these models.
Lipid fluidity was originally suggested to explain the
dependence of channel activity on lipid composition (Fong
and McNamee, 1986) but has subsequently been ruled out
by two studies (Sunshine and McNamee, 1992; Fernandez-
Ballester et al., 1994). Our data support this conclusion. For
example, changes from -20 to 50 mol% cholesterol did not
have any effect, and in one sample (43% cholesterol), when
egg PA was substituted for DOPA, neither the rate nor the
amplitude of the early component changed significantly.
We cannot rule out a "buffering" effect on fluidity in the
lipid-protein interface, which has been postulated to occur
during slow desensitization but not during activation
(Narayanaswami and McNamee, 1993; Sunshine and Mc-
Namee, 1994).
Aggregation has been implicated as an explanation of
lipid modulation of sarcoplasmic reticulum Ca-ATPase ac-
tivity (Cornea and Thomas, 1994). There is some evidence
that in alkali-extracted AcChoR membranes fused with lipid
vesicles, cholesterol may modulate the receptor's rotational
correlation time, perhaps because of aggregation (Rousselet
et al., 1981). This mechanism is unlikely to apply here,
because varying the ratio of phospholipid to receptor at a
constant phospholipid:cholesterol ratio had no effect. For
example, preparations with 400 and 4100 total lipids per
receptor and 12 and 13 mol% cholesterol, respectively, had
very similar rates and fractional amplitudes for the early
component.
Another mechanism, binding of cholesterol, is lent strong
support by our data. The independent evidence is that when
brominated cholesterol is titrated into receptors reconsti-
tuted into dibromo-DOPC, the intrinsic fluorescence is
quenched, with a half-point of -10 mol% cholesterol, and
the effect saturates at -30 mol% cholesterol. Because the
dibromo-DOPC was expected to quench the intrinsic fluo-
rescence at the lipid-protein interface, the additional
quenching by brominated cholesterol was interpreted to
represent binding of cholesterol to nonannular or interstitial
sites. The authors suggested that 5-10 cholesterol binding
sites might be responsible (Jones and McNamee, 1988).
When we normalize the cholesterol titration (Fig. 7) to the
fluorescence quenching data, the agreement of the data is
convincing within experimental error (Fig. 8).
Although there is other evidence for a special role for
cholesterol (it is not possible to remove all of the cholesterol
from native membranes when it is repeatedly extracted into
lipid vesicles (Leibel et al., 1987), AcChoRs have a high
affinity for cholesterol in lipid monolayers (Popot et al.,
1978) and bilayers (Marsh, 1990), and theoretical studies
consistent with nonannular sites have been presented (Or-
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FIGURE 8 Do nonannular cholesterol sites account for cholesterol's
effect on channel activation? The experimental data (0) shows the increase
in quenching of the nAcChoR's intrinsic fluorescence when bromocholes-
terol is added to nAcChoRs reconstituted into dibromo-DOPC (arbitrary
scale). This additional quenching has been attributed to nonannular cho-
lesterol sites (Jones and McNamee, 1988). The solid line has the same
parameters (EC50: 0.09; Hill coefficient: 1.9; minimum: 0.0) of the func-
tional cholesterol titration shown in Fig. 7, except that a nonlinear least-
squares procedure was used to normalize the maximum to the fluorescence
quenching data points.
tells et al., 1992)), one salient observation argues against a
functional role for such sites. That is the remarkable obser-
vation that many other neutral "lipids," such as squalene and
a-tocopherol, can support AcChoR activation in the ab-
sence of cholesterol (Kilian et al., 1980; Sunshine and
McNamee, 1992). Either the putative cholesterol sites have
very loose structural requirements, or some other model is
required. One possible mechanism for cholesterol's action
is the ability for cholesterol to freely flip from one leaflet of
the bilayer to the other to relieve the mechanical stress
caused by membrane bending, if receptor activation were to
involve a conformation change that expanded one leaflet of
the bilayer more than the other. This model would also
accommodate the aforementioned lipids, which can substi-
tute for cholesterol and support receptor activation, because
all of the them can flip across the bilayer as well.
Although the physical mechanism remains unknown, an
interesting corollary is that the channels of newly synthe-
sized receptors are not fully primed by cholesterol until they
are inserted into the plasma membrane-a novel form of
posttranslational processing.
CONCLUSIONS
We have overcome the experimental difficulties imposed by
morphological variation in monitoring agonist-induced
channel activation in reconstituted AcChoRs by developing
a new fluorescence assay based on ethidium. Cholesterol is
absolutely required for activation to occur, but the presence
of a negatively charged lipid is unimportant. Lack of chan-
nel activation is not accounted for by accelerated fast de-
sensitization, because the rate of this process is insensitive
to cholesterol. About half of the receptors are in the resting
state irrespective of lipid composition; therefore they do not
account for lack of activation in the absence of cholesterol.
The number of channels that opened in response to high
agonist concentrations increased with the percentage of
cholesterol in the bilayer, reaching a maximum close to the
fraction of resting-state AcChoRs. The half-point of this
effect is close to 10 mol% cholesterol, which is comparable
to that for saturating the postulated interstitial, or nonannu-
lar, cholesterol sites on the receptor (Jones and McNamee,
1988). In contrast, the subsequent slower conformational
change into the fast desensitized state, A2F, is not modu-
lated by cholesterol.
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